Breaking News Instant updates and real-time market news.

AIR

AAR Corp.

$35.02

-0.075 (-0.21%)

16:03
03/19/19
03/19
16:03
03/19/19
16:03

AAR Corp. sees FY19 adjusted EPS $2.50-$2.57, consensus $2.57

Sees FY19 revenue $2.01B-$2.03B, consensus $2.05B. Sees FY19 adjusted EBITDA in the range of $165M-$170M.

  • 19

    Mar

AIR AAR Corp.
$35.02

-0.075 (-0.21%)

07/11/18
ADAM
07/11/18
NO CHANGE
Target $52
ADAM
Buy
AAR Corp. price target raised to $52 from $48 at Canaccord
Canaccord analyst Ken Herbert maintained a Buy rating on AAR Corp and raised his price target to $52 from $48, telling investors in a research note that the company's Q4 adjusted EPS of 52c was slightly ahead of his 50c estimate, but consistent with prior guidance, with revenues growing 5% from the same quarter last year. Herbert says management indicated that the INL/A contract ramp up is on track, and he continues to see a significant step-up in FY19 EPS and free cash flow, which should be positive for the stock.
09/11/18
RHCO
09/11/18
DOWNGRADE
RHCO
Hold
AAR Corp. downgraded to Hold from Buy at SunTrust
09/11/18
RHCO
09/11/18
DOWNGRADE
Target $47
RHCO
Hold
AAR Corp. downgraded to Hold from Buy at SunTrust
As reported earlier, SunTrust analyst Michael Ciarmoli downgraded AAR Corp to Hold from Buy and lowered his price target to $47 from $50. The analyst notes that he is maintaining a bullish view on the aero aftermarket with an opportunity for AAR Corp to exploit its position while also reaping benefits from its INL Global Aviation Support Services contract, but he also believes that the company's near-term growth will come under pressure from its maintenance, repair, and overhaul, or MRO, segment. He cites tight labor condition in the unit as well as the delays associated with the company's new 737MAX/ A320NEO production, which combine to create a weaker than normal Q1 environment for AAR Corp.
09/11/18
09/11/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. CBS (CBS) downgraded to Neutral from Buy at UBS with analyst John Hodulik saying uncertainty around the management transition limits upside in the shares and could last for an extended period. 2. Tesla (TSLA) downgraded to Neutral from Buy at Nomura Instinet with analyst Romit Shah expressing concern that the "erratic behavior" of CEO Elon Musk will taint the Tesla brand. 3. Johnson Controls (JCI) downgraded to Neutral from Buy at UBS with analyst Steven Winoker saying while the company's Buildings business is improving in 2018, the pace and magnitude of the progress is proving slower and lower than expectations. 4. Wingstop (WING) downgraded to Neutral from Buy at Goldman Sachs with analyst Karen Holthouse saying she continues to view the company's comps and unit growth fundamentals favorably but she recommends taking profits at current share levels. 5. AAR Corp. (AIR) downgraded to Hold from Buy at SunTrust with analyst Michael Ciarmoli saying he is maintaining a bullish view on the aero aftermarket with an opportunity for AAR Corp to exploit its position while also reaping benefits from its INL Global Aviation Support Services contract, but he also believes that the company's near-term growth will come under pressure from its maintenance, repair, and overhaul, or MRO, segment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SGEN

Seattle Genetics

$100.86

13.44 (15.37%)

07:24
10/22/19
10/22
07:24
10/22/19
07:24
Recommendations
Seattle Genetics analyst commentary  »

Seattle Genetics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 07

    Dec

EMHTF

Emerald Health Therapeutics

$0.00

(0.00%)

07:24
10/22/19
10/22
07:24
10/22/19
07:24
Hot Stocks
Emerald Health Therapeutics expands cannabis products to Nova Scotia »

Emerald Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$183.73

7.49 (4.25%)

07:23
10/22/19
10/22
07:23
10/22/19
07:23
Recommendations
Vertex analyst commentary  »

Vertex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 19

    Mar

ORTX

Orchard Therapeutics

$12.09

0.1 (0.83%)

07:22
10/22/19
10/22
07:22
10/22/19
07:22
Hot Stocks
Orchard Therapeutics 'on track' to submit MAA for MLD in 1H20 »

Orchard remains on track…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

BABA

Alibaba

$173.57

4.39 (2.59%)

07:22
10/22/19
10/22
07:22
10/22/19
07:22
Recommendations
Alibaba analyst commentary  »

Daiwa expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 19

    Nov

ORTX

Orchard Therapeutics

$12.09

0.1 (0.83%)

07:21
10/22/19
10/22
07:21
10/22/19
07:21
Hot Stocks
Orchard Therapeutics presents data from OTL-200 in patients with MLD »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SWI

SolarWinds

$19.05

0.22 (1.17%)

07:20
10/22/19
10/22
07:20
10/22/19
07:20
Downgrade
SolarWinds rating change  »

SolarWinds downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

CHTR

Charter

$438.01

-2.45 (-0.56%)

07:20
10/22/19
10/22
07:20
10/22/19
07:20
Recommendations
Charter analyst commentary  »

Charter price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

NVCN

Neovasc

$3.72

0.17 (4.79%)

07:18
10/22/19
10/22
07:18
10/22/19
07:18
Hot Stocks
Neovasc announces multiple presentations featuring Neovasc Reducer »

Neovasc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$3.08

0.17 (5.84%)

07:17
10/22/19
10/22
07:17
10/22/19
07:17
Hot Stocks
Kadmon reports FDA approval of Clovique generic product »

Kadmon Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$262.05

-0.49 (-0.19%)

07:17
10/22/19
10/22
07:17
10/22/19
07:17
Downgrade
Intuit rating change  »

Intuit downgraded to In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

QTRH

Quarterhill

$1.29

0.05 (4.03%)

07:16
10/22/19
10/22
07:16
10/22/19
07:16
Hot Stocks
Quarterhill names David Cortens as interim CFO, succeeding Shaun McEwan »

Quarterhill announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCY

Oncolytics

$0.47

-0.0138 (-2.83%)

, PFE

Pfizer

$36.45

-0.01 (-0.03%)

07:16
10/22/19
10/22
07:16
10/22/19
07:16
Hot Stocks
Oncolytics, PrECOG announce collaboration for Bracelet-1 study in metastatic BC »

Oncolytics Biotech (ONCY)…

ONCY

Oncolytics

$0.47

-0.0138 (-2.83%)

PFE

Pfizer

$36.45

-0.01 (-0.03%)

MKGAY

Merck KGaA

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Dec

KMT

Kennametal

$29.76

-0.97 (-3.16%)

07:16
10/22/19
10/22
07:16
10/22/19
07:16
Recommendations
Kennametal analyst commentary  »

Kennametal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 05

    Nov

  • 14

    Nov

ETON

Eton Pharmaceuticals

$5.66

-0.395 (-6.52%)

07:14
10/22/19
10/22
07:14
10/22/19
07:14
Hot Stocks
Eton Pharmaceuticals announces FDA approval of Biorphen injection »

Eton Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Mar

WDAY

Workday

$154.10

-0.54 (-0.35%)

07:14
10/22/19
10/22
07:14
10/22/19
07:14
Upgrade
Workday rating change  »

Workday upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$118.56

1.23 (1.05%)

07:13
10/22/19
10/22
07:13
10/22/19
07:13
Hot Stocks
UPS announces retirement of COO Jim Barber »

UPS announced COO Jim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

IPG

Interpublic Group

$20.79

0.14 (0.68%)

07:11
10/22/19
10/22
07:11
10/22/19
07:11
Earnings
Interpublic Group 'on track' to deliver high end of 2%-3% organic growth in 2019 »

Consensus $8.65B. CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AAPL

Apple

$240.49

4.2 (1.78%)

07:11
10/22/19
10/22
07:11
10/22/19
07:11
Recommendations
Apple analyst commentary  »

KeyBanc views near-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

PG

Procter & Gamble

$119.04

1.55 (1.32%)

07:10
10/22/19
10/22
07:10
10/22/19
07:10
Hot Stocks
Procter & Gamble: Q1 operating profit margin increased 280 basis points »

Operating profit margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PG

Procter & Gamble

$119.04

1.55 (1.32%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Hot Stocks
Procter & Gamble: Q1 reported gross margin increased 180 basis points »

Q1 Reported gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

VCYT

Veracyte

$26.18

1.52 (6.16%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Hot Stocks
Veracyte announces preliminary nasal swab test clinical data »

Veracyte announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 12

    Dec

PRVB

Provention Bio

$6.09

-0.48 (-7.31%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Hot Stocks
Provention Bio announces results from Phase 2a PRINCE clinical trial »

Provention Bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLAN

Anaplan

$44.35

0.34 (0.77%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Upgrade
Anaplan rating change  »

Anaplan upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPG

Interpublic Group

$20.79

0.14 (0.68%)

07:08
10/22/19
10/22
07:08
10/22/19
07:08
Earnings
Interpublic Group reports Q3 adjusted EPS 49c, consensus 47c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.